Drug Companies Turning to Artificial Intelligence

GlaxoSmithKline, one of the world’s leading drug companies, is turning to artificial intelligence to help streamline the drug discovery process.  Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; socialsecurityreport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.